Cargando…
Hydroxychloroquine safety: A meta-analysis of randomized controlled trials
BACKGROUND: Hydroxychloroquine (HCQ) is currently being examined for COVID-19. No previous meta-analysis has evaluated its side effects versus placebo. We conducted this meta-analysis to compare the safety of HCQ versus placebo. METHODS: Two authors independently searched PubMed and EMBASE databases...
Autores principales: | Eljaaly, Khalid, Alireza, Kasim Huseein, Alshehri, Samah, Al-Tawfiq, Jaffar A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342171/ https://www.ncbi.nlm.nih.gov/pubmed/32645478 http://dx.doi.org/10.1016/j.tmaid.2020.101812 |
Ejemplares similares
-
Colistin Nephrotoxicity: Meta-Analysis of Randomized Controlled Trials
por: Eljaaly, Khalid, et al.
Publicado: (2021) -
Crushing lopinavir-ritonavir tablets may decrease the efficacy of therapy in COVID-19 patients
por: Eljaaly, Khalid, et al.
Publicado: (2020) -
Description and Analysis of Cytokine Storm in Registered COVID-19 Clinical Trials: A Systematic Review
por: Eljaaly, Khalid, et al.
Publicado: (2021) -
Histamine release theory and roles of antihistamine in the treatment of cytokines storm of COVID-19
por: Eldanasory, Omar Abdelhay, et al.
Publicado: (2020) -
The effect of erythromycin and clarithromycin versus azithromycin on serum valproate concentration
por: Albanji, Muradi, et al.
Publicado: (2022)